TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pain satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Angina measured by Seattle Angina Questionnaire (SAQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angina measured by SAQ-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial perfusion reserve index (MPRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of pain on injection of propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2 or greater OPN
Endpoint domain: Adverse events/effects
Primary endpoint: Correctly sited catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overinsertion of umbilical arterial catheter
Endpoint domain: Adverse events/effects
Primary endpoint: L-selectin down-regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in back symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of late grade ≥2 xerostomia
Endpoint domain: Adverse events/effects
Primary endpoint: mean SMG doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Salivary gland outcomes
Primary endpoint: median doses to oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Trunk function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal anti‐Porphyromonas gingivalis IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk for preterm delivery
Endpoint domain: Mortality/survival
Primary endpoint: mean monthly frequency of attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients reporting 100% remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of disease-specific QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in OHRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: nonsuicide mortality within 1 year
Endpoint domain: Mortality/survival
Primary endpoint: probability of presenting a severe event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported health (EQ-5D index scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight loss of 5% or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss greater than 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracheal intubation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difficulty of tracheal intubation (visual analogue scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracheal intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum levels of platelet activation indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recurrence of symptoms of de Quervain disease
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in children's anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-treatment-failure (TTF)
Endpoint domain: Mortality/survival
Primary endpoint: Cardiovascular death or unplanned admission to hospital for worsening HF
Endpoint domain: Mortality/survival
Primary endpoint: Threshold allergen concentration for type I hypersensitivity reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Atopy patch test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sagittal plane hindfoot motion restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sagittal plane forefoot motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal socket bone fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resorption of alveolar bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal resorption of the alveolar bony ridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total resolution of thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Persistent mid-thigh pain
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of orthodontic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work presenteeism
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 12-month brain tumor recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Need for salvage brain treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: total drug consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean total adherent dandruff score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of irritation and itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Problem-solving skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reviewer rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduced school absenteeism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: reduced hyperactivity, aggressiveness, externalization, and socio‐deviant conduct
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: larger volume of the left caudate nucleus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Undetectable PSA rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average cost per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Qualified success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in agitation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in prescribed opioid dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total fat purchases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CD4+ T-lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compliance
Endpoint domain: Resource use
Primary endpoint: Duration of pressure ulcer formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Complete response (CR) of at least one target tophus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in tophus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of gout flares requiring treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: foot function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical results of conservative management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS mean score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications from procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Ham-D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite outcome of cardiovascular death, myocardial infarction, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: developmental deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Informativeness of digital images compared to color slides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Confirmed or suspected infection within 6 weeks of giving birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient-reported treatment effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: myocardial ischaemia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systemic vascular resistance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stroke work index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Learning of standard Braille
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of oxygen supplementation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time required for normalization of clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of cervical dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NYHA classification improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute kidney rejection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: brain atrophy progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of participants
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of fiber supplement consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Association of SNPs with PD phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: binge abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of atheromatous plaque debris in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: estimated pulmonary artery diastolic pressure (ePAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average weight‐bearing maximal flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average amount of posterior femoral roll‐back
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transfusion rates
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive improvement as measured by SLT and DSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Association of height with varicose veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Uptake of couples HIV counseling
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: CC quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in percent breast density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of psoriatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean number of treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative UVA dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cumulative UVB dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rates of VPC asthma improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 5-year mortality risk associated with the wish to die
Endpoint domain: Mortality/survival
Primary endpoint: clinical improvement in depressive symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak exercise heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IMR immediately post-PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cTnI 24 hours post-PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cTnI elevation >0.20 ng/mL
Endpoint domain: Adverse events/effects
Primary endpoint: number of adhesion formation
Endpoint domain: Adverse events/effects
Primary endpoint: severity of adhesions
Endpoint domain: Adverse events/effects
Primary endpoint: Total neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: suicide risk assessment proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent CR plus CRp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triggering delay time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: work of breathing (WOB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean fixation times in the nasal region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cerebral microemboli (HITS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100 beta levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary abstinence in adolescent boys
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consistent condom use in adolescent girls
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Keeping to one partner in both genders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptomatic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EHF emptying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diuresis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve maximum sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome expectations of OTC pain medications
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral capabilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preventive behavior intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement or resolution of abdominal cramping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of unformed stools on day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: earlier extubation after discontinuation of anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: shortened period of long-term withdrawal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mandibular dental asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord pH in neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill development scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secretion of interleukin‐8 from adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adipose tissue expression of thioredoxin‐inhibitory protein (TxNIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: C(50) of remifentanil for laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(50) of remifentanil for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(50) of remifentanil for intraabdominal surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(50) of propofol for return to consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antagonistic effects to angiotensin II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of antagonistic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receptor occupancy percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak median change in milk output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depressive symptoms measured with the BDI‐II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of refractory sprue
Endpoint domain: Adverse events/effects
Primary endpoint: time to perform functional tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD of the trochanter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gain in letters from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful insertion at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall success rate of insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response shift evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inflammation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Hyphema rate
Endpoint domain: Adverse events/effects
Primary endpoint: Transition to mature stages of nonnutritive sucking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of sucking bursts during breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Straight Leg Raise (SLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YBOCS 'Compulsions' subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate (YBOCS ≥35% reduction)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Eradication rates of CRE colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Type of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of episodes of acute rejection per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: quality of psychological health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: quality of social relationships
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Recurrence risk prediction
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in new purpura lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in skin's appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nonadherence to antidepressants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SD of the steering position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time to target stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vmca
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in implant cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effectiveness of iCBT programme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to iCBT programme
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: delirium/coma-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence with CPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular discomfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Episodes of acute pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean serum amylase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hemangioma Activity Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during mobilization 2 h after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total IV morphine use 0-4 h
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Decrease in effluent IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes